Traditional monocytes show a CD14++ CD16− phenotype, non-traditional monocytes show a CD14 ++ CD16 + and an intermediate CD14+ CD16++ phenotype (35), all differentially contributing to MS immunopathology. This evidence concerns the gene CD14 and myeloid sarcoma.